Synthetic data for privacy-preserving clinical risk prediction
Synthetic data promise privacy-preserving data sharing for healthcare research and development. Compared with other privacy-enhancing approaches-such as federated learning-analyses performed on synthetic data can be applied downstream without modification, such that synthetic data can act in place of real data for a wide range of use cases. However, the role that synthetic data might play in all aspects of clinical model development remains unknown. In this work, we used state-of-the-art generators explicitly designed for privacy preservation to create a synthetic version of ever-smokers in the UK Biobank before building prognostic models for lung cancer under several data release assumptions. We demonstrate that synthetic data can be effectively used throughout the medical prognostic modeling pipeline even without eventual access to the real data. Furthermore, we show the implications of different data release approaches on how synthetic biobank data could be deployed within the healthcare system.
Authors
- Mihaela van der Schaar (ORCID: https://orcid.org/0000-0003-3933-6049)
- Neal Navani (ORCID: https://orcid.org/0000-0002-6412-7516)
- Bogdan Cebere
- Zhaozhi Qian (ORCID: https://orcid.org/0000-0002-4561-0342)
- Thomas Callender (ORCID: https://orcid.org/0000-0001-8440-9433)
- Sam M. Janes (ORCID: https://orcid.org/0000-0002-6634-5939)
Institutions
- Turing Institute (GB)
- University of Cambridge (GB)
- University College London (GB)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1038/s41598-024-72894-y
- Citations
- 30
- Primary Topic
- Privacy-Preserving Technologies in Data
- Type
- article
- Field-Weighted Citation Impact
- 10.42
Funders
- Health and Care Research Wales
- Cancer Research UK
- Medical Research Council